Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (64,126)	$ (32,547)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	13,737	4,847
Stock-based compensation expense	28,827	2,379
Loss on disposal of assets	25	55
Gain (Loss) on Extinguishment of Debt	0	496
Amortization of debt issuance costs and discount	1,392	149
Noncash lease expense	1,526	997
Noncash (income) expense associated with liability-classified warrants	(13,482)	5,478
Deferred income taxes	251	(612)
Changes in operating assets and liabilities:
Accounts receivable	(12,926)	(19,580)
Contract assets	(2,286)	1,201
Inventories	(16,302)	(5,347)
Prepaids and other current assets	(8,090)	2,796
Other non-current assets	2,089	0
Trade payables	1,992	(3,384)
Accrued expenses	(3,433)	2,849
Employee benefits payables	3,925	756
Contract liabilities	4,467	5,006
Other current liabilities	(568)	(930)
Non-current lease liabilities	(1,640)	(1,191)
Other non-current liabilities	27	0
Net cash used in operating activities	(64,595)	(36,582)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, equipment and software	(19,070)	(5,699)
Cash paid for acquisition, net of acquired cash and restricted cash	(65,073)	0
Net cash used in investing activities	(84,143)	(5,699)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the exercise of stock options and public warrants	3,142	772
Proceeds from Employee Stock Purchase Plan	2,091	0
Proceeds from sale of employees restricted stock units to cover taxes	24,002	0
Minimum tax withholding paid on behalf of employees for restricted stock units	(23,741)	0
Tax payment for net settled option shares	(444)	0
Payment of contingent consideration	(5,500)	0
Finance lease principal payments	(116)	0
Proceeds from long-term revolving line of credit	0	15,000
Proceeds from long-term secured term loan	0	98,895
Repayments on long-term revolving line of credit	0	(15,000)
Payment of deferred transaction costs associated with planned reverse recapitalization transaction	0	(2,298)
Net cash provided by financing activities	(566)	97,369
Effect of exchange rate changes on cash and cash equivalents	3,858	20
Net decrease in cash and cash equivalents and restricted cash	(145,446)	55,108
Cash and cash equivalents, and restricted cash, beginning of period	692,075	53,933
Cash and cash equivalents, and restricted cash, end of period	546,629	109,041
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest	4,771	0
Cash paid for income taxes	2,028	0
Unpaid purchases of property, equipment and software	1,027	1,231
Deferred transaction costs in accrued expenses	0	1,096
Right-of-use assets obtained in exchange for new operating lease liabilities	3,783	0
Net exercise of public and private warrants into common stock	44,739	0
Issuance of common stock for payment of accrued bonus	$ 1,441	$ 0